The phenomenon of cross-reactivity between allergenic proteins plays an important role to understand how the immune system recognizes different antigen proteins. Allergen proteins are known to cross-react if their sequence comparison shows a high sequence identity which also implies that the proteins have a similar 3D fold. In such cases, linear sequence alignment methods are frequently used to predict cross-reactivity between allergenic proteins. However, the prediction of cross-reactivity between distantly related allergens continues to be a challenging task. To overcome this problem, we developed a new structure-based computational method, Cross-React, to predict cross-reactivity between allergenic proteins available in the Structural Database of Allergens (SDAP). Our method is based on the hypothesis that we can find surface patches on 3D structures of potential allergens with amino acid compositions similar to an epitope in a known allergen. We applied the Cross-React method to a diverse set of seven allergens, and successfully identified several cross-reactive allergens with high to moderate sequence identity which have also been experimentally shown to cross-react. Based on these findings, we suggest that CrossReact can be used as a predictive tool to assess protein allergenicity and cross-reactivity.
Introduction
The immune system induces an IgE response to certain antigens that resemble primary sensitizing antigens. This phenomenon is known as cross-reactivity (CR). Considerable amount of experimental and theoretical work has been done to characterize the sequences and substructures of allergens that account for their cross-reactivity (Aalberse, 2000; Aalberse et al., 2001; Breiteneder and Mills, 2006; Fedorov et al., 1997; Ivanciuc et al., 2009a; Ivanciuc et al., 2009b) . Earlier studies have shown that an antibody (Ab) recognizes and binds to a specific region on an antigen (Ag) surface known as epitope. An epitope can be a linear contiguous sequence of amino acids (known as linear epitope) or a group of sequentially separated amino acids in a protein sequence brought together by protein folding (known as conformational epitope). Compared to a linear epitope, a conformational epitope provides a correct scaffold for an antigenic determinant which is crucial for Ag-Ab interaction, identification of cross-reactive allergens, and development of new vaccines and therapeutics to treat allergenic diseases (Jutel et al., 2016; Metcalfe, 2005; Tilles, 2016) . It is believed that more than 90% of the clinically important epitopes recognized by antibodies are conformational in nature (Barlow et al., 1986; Haste Andersen et al., 2006; Van Regenmortel, 1996) . The precise location of conformational epitope can be determined by X-ray crystallography, but solving co-crystal structure of an Ag-Ab complex is challenging, expensive and time-consuming. To overcome this problem, phage display technology (Smith, 1985) has been successfully used to characterize Ag-Ab interactions (Mittag et al., 2006; Untersmayr et al., 2006) . It has been shown that peptides selected by phage display mimic conformational epitopes on an antigen protein. But due to lack of consensus in the phage displayed peptides, mapping IgE binding sites (epitope) onto three-dimensional (3D) allergen structure is a challenging task (Chen et al., 2016; Mayrose et al., 2007; Negi and Braun, 2009; Tiwari et al., 2012) .
In most cases, the specificity of an antibody depends on a unique composition of amino acids at the epitope site. Thus, an antibody raised against one allergen may cross-react to similar allergens from different sources if they have high sequence or structural identity (Aalberse, 2000; Breiteneder and Mills, 2006; Dall'antonia et al., 2014; Garcia and Lizaso, 2011) . In such cases, potential crossreactive allergens can be identified using global sequence alignment methods such as PSI-BLAST (Altschul et al., 1997) or FASTA (Pearson, 1994) . Alternatively, local peptide sequence similarity method such as property distance (PD) can be applied (Ivanciuc et al., 2009a) . However, these methods fail to detect cross-reactivity between distantly related allergens (Aalberse, 2000; Aalberse et al., 2001; Breiteneder and Mills, 2006; Garcia and Lizaso, 2011; Guhsl et al., 2014; Metcalfe, 2005; Vieths et al., 2002; Weber, 2007) . The definition of in vitro cross-reactivity of allergens should be distinguished from multi-sensitization in the clinical observation when a patient is exposed and sensitized to different allergen sources (Aalberse and Aalberse, 2015) . In that case cross-reactivity might be due to binding of allergens to different IgE antibodies.
In the past, several computational methods have been developed to predict epitope sites on protein antigens (El-Manzalawy et al., 2008; Singh et al., 2013; Yao et al., 2012) . Most of these methods use a small linear segment of 6-10 amino acids to search for the epitopes. These methods are very useful to predict linear epitopes, but are limited to predict the location of conformational epitopes. Epitope prediction methods using structural properties of proteins have previously been reviewed by Dall'antonia et al. (2014) . DiscoTope (Haste Andersen et al., 2006; Larsen et al., 2006) , ElliPro (Ponomarenko et al., 2008) and SPADE (Dall'Antonia et al., 2011) uses 3D structure of an antigen, while PepSurf (Mayrose et al., 2007) and EpiSearch (Negi and Braun, 2009 ) uses both 3D structure and phage display data, to predict conformational epitopes. However, all the methods developed so far are not designed for rapid large-scale screening of allergen cross-reactivity using epitope information.
Our objective was to find structural features of allergens responsible for their allergenicity and cross-reactivity with other allergens available in SDAP, a database that contains over a thousand 3D structures of allergens determined by X-ray crystallography or homology modeling (Ivanciuc et al., 2003; Oezguen et al., 2008; Power et al., 2013) . All modeled structures in the SDAP database have been energy minimized by FANTOM using ECEPP/2 force field (Ivanciuc et al., 2003; Nemethy et al., 1983; Oezguen et al., 2008; Schaumann et al., 1990) and validated by comparison with new allergen structures released in the PDB (Power et al., 2013) . In addition, due to large number of allergens in SDAP, we wanted the predictions to be rapid and efficient to perform such a large-scale structural bioinformatics analysis.
With this intent, we developed a new structure-based method, Cross-React, that enables prediction of cross-reactivity between distantly related allergenic proteins using their X-ray or homology modeled structures in combination with epitope analysis. The method uses a patch analysis, solvent accessible surface area (SASA) of amino acids, and structural similarity between amino acids in the epitope region of a query allergen and allergens in the SDAP database (target allergens). The search results are ranked based on the calculated Pearson correlation coefficient (PCC) between the amino acid composition in the query epitope and the accessible surface patches on the target allergens. We tested the performance of CrossReact for seven different allergenic proteins which have also been experimentally shown to cross-react (Ferreira et al., 2004; Ivanciuc et al., 2003; Konstantinou and Grattan, 2008; Mari et al., 2006) . Our analysis successfully predicted cross-reactive allergens which have similar tertiary structure, high PCC value and >30% sequence identity with the query allergen.
Methods

Selection of query allergens for Cross-React analysis
The query data set of seven allergenic proteins was divided into two types: Type I and Type II, depending on the nature of their experimentally determined epitopes. Type I included the allergenic proteins from birch pollen (Bet v 1) (Gajhede et al., 1996) , grass pollen (Phl p 2) (Padavattan et al., 2009) , honey bee venom (Api m 2) (Padavattan et al., 2007) , and bovine milk (Bos d 5) (Niemi et al., 2007) . For each of these allergens, location of the conformational epitope has previously been determined by X-ray crystallography of the allergen-Ab complex. Type II included the allergenic proteins from peach (Pru p 3) and peanut (Ara h 1 and Ara h 2), where cocrystal structures of allergen-Ab complexes are not available. Hence, we first mapped the potential conformational epitopes by using mimotopes from phage display for Pru p 3 (Pacios et al., 2008) , and linear epitopes for Ara h 1 and Ara h 2 (Ara h 1/2) (Barre et al., 2005a; Barre et al., 2005b) onto 3D structures determined by X-ray crystallography (Pru p 3 and Ara h 1) or homology modeling (Ara h 2).
Selection of amino acids in IgE binding site
Conformational epitope in a Type I allergen was defined as a change in the SASA of amino acids in the allergen upon formation of an allergen-Ab complex. The SASA values were calculated using GETAREA (Fraczkiewicz and Braun, 1998 ) with a probe of radius 1.4 Å . The amino acids on the antigen surface were considered to be part of an epitope if they lost more than 10 Å 2 of SASA upon allergen-Ab complex formation (Negi and Braun, 2007; Negi et al., 2007) . For the Type II allergen Pru p 3, we used peptides selected from phage display (Pacios et al., 2008) in combination with EpiSearch (Negi and Braun, 2009 ) and PepSurf (Mayrose et al., 2007) to map conformational epitopes. For Ara h 1/2, conformational epitopes were defined as a group of amino acids in a spherical patch around a surface exposed residue located at the center of a linear epitope.
Connectivity matrix
We introduced a connectivity matrix C 1 to describe the composition of surface exposed residues in a conformational epitope on a query allergen. The connectivity matrix is a 20x20 matrix which counts how often C b atoms of the amino acids in the epitope region are in contact with other residues. Two amino acids were considered to be connected if the distance between their C b atoms (C a for Gly residue) was 8 Å . Similarly, a connectivity matrix C 2 was constructed for all surface exposed residues on a target allergen. The matrix counts the connections between amino acids present in a patch of radius 10 Å centered on a surface exposed residue in the target allergen. Thus, the total number of surface patches on the target allergen is equal to the number of surface exposed residues.
Correlation between connectivity matrices
The cross-reactivity between query and target allergen was assessed by calculating the correlation coefficient between connectivity matrices of query epitope and a surface patch on the target allergen. This process was repeated for all the surface patches on the target allergen. For the patch analysis, the SASA of amino acids in all the allergens were calculated using GETAREA, and amino acids with SASA greater than 10 Å 2 were selected and replaced by their C b atoms (C a in case of Gly residue). Next, we defined a spherical test patch of radius 10 Å around each surface exposed residue using their C b atom as center. To improve search efficiency, we precomputed the connectivity matrices of all test patches to generate over one hundred thousand connectivity matrices. The similarities between epitope site on the query allergen and test patches on the target allergen were measured by calculating the Pearson correlation coefficient (PCC) between the connectivity matrices C 1 and C 2 as defined in equation 1
where N is the total number of elements in the connectivity matrix.
Prediction of cross-reactivity
Potential cross-reacting allergens were predicted by comparing: 3D structure of query allergen with the allergens in SDAP database, and the PCC value between query and predicted epitope. The structural alignment between query and target allergen was calculated using the combinatorial extension (CE) method (Shindyalov and Bourne, 1998) . Based on the CE sequence identity, all the predicted allergens in SDAP were divided into two groups. The structural identity between query and predicted allergens was >60% for Group I, and 30-60% for Group II. Finally, the allergens predicted in each group were sorted based on the PCC value of surface patches.
Results and discussion
We investigated the performance of Cross-React using a diverse set of seven query allergens. As shown in Tables 1 and 2 , the predicted allergens in Group I share high PCC value, high sequence and structural identity with the query allergen; and therefore represent strong candidates for cross-reactivity. The allergens predicted in Group II have moderate sequence identity, but high PCC value and similar 3D fold as the query allergen; and therefore represent probable candidates for cross-reactivity. In the following sections, we document our findings with Cross-React.
3.1 Type I: crystal structure of query allergen in complex with antibody is available
Before performing large scale SDAP database search, we first confirmed the ability of Cross-React method to correctly predict the experimentally known epitope site in Type I query allergens. The method identified all epitopes with PCC value: 0.99 for Bet v 1, 0.93 for Phl p 2 and 0.93 for Api m 2. In our cross-reactivity analysis a slightly lower PCC value is expected because computationally predicted epitopes are spherical patches on the allergen surface while natural epitope sites are not. Further, we tested the performance of Cross-React to find similar or distantly related allergens for Bet v 1, Phl p 2, Api m 2 and Bos d 5 using experimentally known epitope as input, and is described in the following sections.
Bet v 1 is a major birch pollen allergen that accounts for health problems related to pollen allergies in more than 20% of the European population (Ganglberger et al., 2000) . It is one of the most studied allergen and is known to cross-react with several other allergens (Vieths et al., 2002) . Patients sensitized to Bet v 1 can develop allergic reactions towards other plant derived foods such as apple (Mal d 1), cherry (Pru av 1), carrots (Dau c 1) and celery (Api g 1) (Aalberse, 2000; Breiteneder and Mills, 2006; Ganglberger et al., 2000; Jensen-jarolim et al., 1998; Klinglmayr et al., 2009; Thomas et al., 2005) . In order to search for allergens with distribution of amino acids similar to Bet v 1 epitope, we first created a connectivity matrix of amino acids present in the Bet v 1 epitope region using the crystal structure of Bet v 1-mAb BV16 complex (Gajhede et al., 1996; Mirza et al., 2000) . This information was then used to search the SDAP database using Cross-React. A closer examination of the results revealed that the method predicted the epitope similar to Bet v 1 in Group I (Aln g Fig. 1a-c) . The predicted epitopes in Group I allergens are surface patches with high PCC values and are spatially located in the same position relative to the experimentally known epitope of Bet v 1. The predicted allergens in Group II have moderate sequence identity of 30-60% with Bet v 1.
Next, we identified potential cross-reactive allergens for Phl p 2, Api m 2 and Bos d 5 using the methodology described for Bet v 1. The epitope of grass pollen allergen Phl p 2 consists of 15 surface exposed residues from four-stranded antiparallel beta strands (Padavattan et al., 2009) . In this case, Cross-React predicted several allergens with epitopes structurally similar to Phl p 2 (Table 1) . Of particular interest is the experimentally known cross-reactive allergen Phl p 1 from timothy grass which has $43% sequence identity with Phl p 2. Api m 2 is a 350 residue allergen protein found in honey bee venom. The epitope of Api m 2 is composed of a continuous group of nine surface exposed amino acids (Padavattan et al., 2007) . Using Api m 2 epitope information as input, Cross-React efficiently predicted Ves v 2 (wasp venom) and Dol m 2 (white face hornet) as cross-reactive allergens of Api m 2, despite moderate PCC value and moderate sequence identity (Table 1 , Fig. 1d-f) .
Finally, for the bovine milk allergen Bos d 5 (Niemi et al., 2007) , we predicted Asp f 3 and Bla g 4 as cross-reactive allergens which have less than 30% structural identity with Bos d 5. It is interesting to note that Bla g 4 and Bos d 5 belong to lipocalin group of proteins (Tan et al., 2009) , however, it is not known whether these allergens cross-react under experimental conditions. Based on our findings so far, we suggest that the prediction accuracy of Cross-React analysis is higher if the sequence or structural identity between a query allergen and target allergens in SDAP is more than 30%, and the PCC value is greater than 0.70.
Type II: crystal structure of query allergen in complex with antibody is not available
In this case, we investigated three allergens Pru p 3, Ara h 1/2. In the absence of crystal structures, we mapped the epitopes for Pru p 3 and Ara h 1/2 using phage display peptides and linear epitopes, respectively.
Peach allergen Pru p 3 is a common plant food allergen in Europe and Mediterranean (Borges et al., 2007; Chen et al., 2008; Pacios et al., 2008) . In an earlier attempt to map the conformational epitopes of Pru p 3, Pacios et al. used a consensus sequence obtained from phage display and identified two overlapping groups of amino acids: (i) between helix 2 and helix 3 and (ii) in the C-terminal Structure alignment identity was calculated using CE structure alignment method (CE ID).
e RMSD was calculated using CE method. region. In another study, Borges et al. used hydropathy profile of Pru p 3 and predicted four linear IgE epitopes. A comparison between the above two methods revealed that the amino acids in the second linear epitope predicted by the hydropathy profile method are conserved in proteins from Pru p 3 family, and are similar to those in the epitope region predicted using phage display. Further, we analyzed the mimotope data for Pru p 3 using EpiSearch and PepSurf. Both methods predicted a similar group of amino acids that coincided with the previously known epitope in Pru p 3. The epitope information for Pru p 3 obtained using the computational approach was used to search the SDAP database for allergens with similar epitopes. Our Cross-React method predicted potential cross-reactive allergens Pru av 3, Heb b 12, Pru ar 3 and Zea m 14 with high PCC values (Table 2) . In all these allergens, the potential epitope patches were found within similar 3D location as observed in Pru p 3 (Fig.  2a-c) . We also observed that the predicted epitopes on these allergens are surface exposed and hence could account for their crossreactivity (Breiteneder and Mills, 2006; Garcia-Casado et al., 2003; Pastorello et al., 2000) .
To confirm the feasibility of our method for predicted epitopes, the Cross-React analysis for Bet v 1 was repeated using the methodology similar to that described above for Pru p 3. We selected five phage displayed peptides that mimic Bet v 1 conformational epitope (Ganglberger et al., 2000) and mapped them onto Bet v 1 crystal structure using EpiSearch. The method predicted a high scoring patch centered on V67 that overlapped with the Bet v 1 epitope previously identified by X-ray crystallography and site directed mutagenesis (Mirza et al., 2000; Spangfort et al., 2003) . Further, Cross-React analysis of the predicted Bet v 1 epitope identified cross-reactive allergens same as those shown in Table 1 .
Next, we analyzed two major peanut allergens Ara h 1/2 (Barre et al., 2005b; de Leon et al., 2007; Koppelman et al., 2005; Naganawa et al., 2008) . Ara h 1 is a two domain allergen protein with similar fold but different sequences and forms a homotrimer through hydrophobic interactions. Earlier experimental studies using individual patient sera have shown that antibodies recognize twenty three linear epitopes in Ara h 1 (Shin et al., 1998) , and ten linear epitopes in Ara h 2 (Barre et al., 2005a) . For the crossreactivity analysis of Ara h 1, we selected one major linear epitope (epitope 18, HRIFLAGDKD) and searched for its 3D homologs in SDAP using a patch size of 10 Å (as described in the method section). Cross-React predicted similar conformational epitope in: Gly m conglycinin, Jug r 2, Jug n 2, Ana o 1 and Cor a 11 (Table  2 , Fig. 2d-f) . In case of Ara h 2, we selected a high binding IgE epitope (epitope 2, DRRCQSQLER) (Barre et al., 2005b) for the Cross-React analysis, and predicted similar conformational epitope in Ara h 6, Ara h 7, Sin a 7 and Hor v 1. The alignment results obtained from CE and FASTA show that Ara h 2 has high sequence and structural homology with Ara h 6, but low homology with Sin a 7, Ara h 7 and Hor v 1. Thus, by performing Cross-React analysis using a linear epitope, we have demonstrated the effectiveness of our method to predict potential cross-reactive allergens in the absence of known conformational epitopes.
Special case
To further evaluate our method, we performed Cross-React analysis for Bla g 2, a major cockroach allergen for which cross-reactive allergens are still unknown. We extracted Bla g 2 epitope information from the crystal structure of Bla g 2 in complex with mAb 7C11 (Li et al., 2008) . Our method did not find allergen surface patches with amino acids composition similar to those observed in the Bla g 2 epitope. In order to confirm our findings, we searched the SDAP database for Bla g 2 homologs using FASTA, and identified only one allergen Asp f 10 which has $19% sequence identity with Bla g 2.
Clinical implications of cross-reactivity
In a clinical setting, serum of patients can be analyzed by component-resolved diagnostics (CRD) to determine if the serum IgE antibodies react to different purified allergens (Aalberse, 2007; Gadermaier et al., 2011) . A positive reaction of a patient serum in those experiments can have two different reasons: a) the patient has been previously exposed to different allergen sources and different IgE antibodies were induced, or b) a single IgE antibody in the serum binds to different allergens. In this study, we used the term crossreactivity only for the second case which can be confirmed by invitro binding studies of isolated monoclonal IgE antibodies. Another reason for the observation of clinical cross-reactivity can be attributed to cross-reactive carbohydrate determinants (CCD) (Foetisch et al., 2003; Mari et al., 1999) . It has been shown that some of the CCDs are highly cross-reactive and responsible for IgE reactivity Fig. 1 . Comparison of epitope sites in Type I query allergens and predicted cross-reactive allergens. All allergens are shown as ribbon models (grey). The epitope site residues are shown as sticks in Type I query allergens (red), and cross-reactive allergens (green) predicted using Cross-React. Only epitope site is shown for Api m 2, Ves v 2 and Dol m 2 (Color version of this figure is available at Bioinformatics online.) Fig. 2 . Comparison of epitope sites in Type II query allergens and predicted cross-reactive allergens. All allergens are shown as ribbon models (grey). The epitope site residues are shown as sticks in Type II query allergens (red), and cross-reactive allergens (green) predicted using Cross-React. Only epitope site is shown for Ara h 1, Gly m conglycinin and Jug r 2 (Color version of this figure is available at Bioinformatics online.) against plant and animal derived foods. Although clinical relevance of IgE specific for CCDs is still a matter of debate, they may represent a special case of panallergenic structures responsible for IgE cross-reactivity (Ferreira et al., 2004; Hauser et al., 2010) . On the other hand, sequence and structural analysis of allergenic proteins suggests that the allergens can be grouped into panallergen families which share conserved motifs, 3D structures, function and crossreactive epitopes. Hence, better understanding of amino acids in the epitope site and 3D structure of panallergens will improve diagnosis and treatment of allergenic diseases.
Implementation
A user friendly and fully automated version of the Cross-React method presented in this work is available online (http://curie.utmb. edu/Cross-React.html). To perform cross-reactivity analysis, users can upload X-ray or homology model structure of a query allergen as a PDB-formatted file, a list of amino acids in the allergen epitope site, and enter values for SASA and patch size threshold. The predicted results are displayed in a tabular form with name of the crossreactive allergen, PCC value, its sequence identity with the query allergen and location of epitope on the cross-reactive allergen. In addition, user can also view a comparison between epitope sites on the query and the predicted cross-reactive allergens using JMOL molecular viewer (JMOL, 2007) . The average time to process a query allergen may vary from 1 to 2 min.
Conclusion
Sensitization by an allergen induces IgE antibodies which can be cross-reactive to other allergen proteins with similar sequences or 3D folds in their tertiary structure. In the current work, we have developed and tested a new method, Cross-React, to predict crossreactivity between allergenic proteins by comparing structural similarity between amino acids present in the epitope site. Using the concept of connectivity between amino acids within the epitope site in combination with data mining techniques, we have correctly predicted allergens which have also been experimentally shown to cross-react. Further, we suggest that the Cross-React method will help to understand why only selected proteins of the same family are cross-reactive, e.g. homologous of Bet v 1 in vegetables cause severe while those in fruit cause mild allergic reactions (Vieths et al., 2002) . We conclude that the structure-based computational method presented here will improve our understanding of allergen crossreactivity, and help in development of new standardized approaches to immunotherapy and formulation practices.
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